Monotherapy versus β-lactam-aminoglycoside combination therapy for gram-negative bacteremia [3] (multiple letters)

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	2593-2594
Number of pages	2
Journal	Antimicrobial Agents and Chemotherapy
Volume	41
Issue number	11
DOIs	https://doi.org/10.1128/aac.41.11.2593
State	Published - 1997
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{2c45a85eae4e499c8eb660194bc710ba,

title = "Monotherapy versus β-lactam-aminoglycoside combination therapy for gram-negative bacteremia [3] (multiple letters)",

author = "Falagas, {M. E.} and L. Leibovici",

year = "1997",

doi = "10.1128/aac.41.11.2593",

language = "אנגלית",

volume = "41",

pages = "2593--2594",

journal = "Antimicrobial Agents and Chemotherapy",

issn = "0066-4804",

publisher = "American Society for Microbiology",

number = "11",

}

TY - JOUR

T1 - Monotherapy versus β-lactam-aminoglycoside combination therapy for gram-negative bacteremia [3] (multiple letters)

AU - Falagas, M. E.

AU - Leibovici, L.

PY - 1997

Y1 - 1997

UR - http://www.scopus.com/inward/record.url?scp=0030664632&partnerID=8YFLogxK

U2 - 10.1128/aac.41.11.2593

DO - 10.1128/aac.41.11.2593

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.letter???

C2 - 9371379

AN - SCOPUS:0030664632

VL - 41

SP - 2593

EP - 2594

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 11

ER -